- Investing.com
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.
Metrics to compare | 0QNO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship0QNOPeersSector | |
---|---|---|---|---|
P/E Ratio | 65.4x | 25.3x | −0.7x | |
PEG Ratio | −1.39 | −0.28 | 0.00 | |
Price/Book | 4.0x | 3.2x | 2.6x | |
Price / LTM Sales | 5.6x | 4.1x | 3.2x | |
Upside (Analyst Target) | - | 25.0% | 44.1% | |
Fair Value Upside | Unlock | 5.7% | 8.2% | Unlock |